[
  {
    "ts": "2025-12-19T13:59:00+00:00",
    "headline": "Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema",
    "summary": "NVO files an NDA with the FDA for once-weekly CagriSema, a combo obesity injection showing superior weight loss in obese patients in phase III studies.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-files-nda-next-135900065.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a4acac6a-21ec-3f28-a403-b9b9ec0480d2",
      "content": {
        "id": "a4acac6a-21ec-3f28-a403-b9b9ec0480d2",
        "contentType": "STORY",
        "title": "Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema",
        "description": "",
        "summary": "NVO files an NDA with the FDA for once-weekly CagriSema, a combo obesity injection showing superior weight loss in obese patients in phase III studies.",
        "pubDate": "2025-12-19T13:59:00Z",
        "displayTime": "2025-12-19T13:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OpV4giEb4QjgN71LPYFzIw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QcLiFahMpkHBfBp4mOYpEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-files-nda-next-135900065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-files-nda-next-135900065.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T13:09:17+00:00",
    "headline": "Dow Jones Futures: Tech Stocks Eye Key Level; Oracle, Nike, FedEx In Focus",
    "summary": "Futures signal the stock market may test key resistance again after Thursday's Micron-inflation gains. Oracle, FedEx, Nike are early movers.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-micron-cool-inflation-nike-fed-earnings/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "f226d2f7-9938-3b8e-b27f-83c71154c6f0",
      "content": {
        "id": "f226d2f7-9938-3b8e-b27f-83c71154c6f0",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Tech Stocks Eye Key Level; Oracle, Nike, FedEx In Focus",
        "description": "",
        "summary": "Futures signal the stock market may test key resistance again after Thursday's Micron-inflation gains. Oracle, FedEx, Nike are early movers.",
        "pubDate": "2025-12-19T13:09:17Z",
        "displayTime": "2025-12-19T13:09:17Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f226d2f7-9938-3b8e-b27f-83c71154c6f0/dow-jones-futures-tech.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/321e302698876aa86dd10df643900695",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oVfVEeaR27sq2IXfqgIXsA--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/321e302698876aa86dd10df643900695.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K0OQOn8hh6tqhnD.fMcIdA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/321e302698876aa86dd10df643900695.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-micron-cool-inflation-nike-fed-earnings/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "FDX"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "RDDT"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "GMED"
            },
            {
              "symbol": "GTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T11:40:40+00:00",
    "headline": "Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs",
    "summary": "Lilly has now submitted a new drug application (NDA) for orforglipron to the FDA for use in adults with obesity.",
    "url": "https://www.clinicaltrialsarena.com/news/eli-lilly-orforglipron-phase-iii-obesity-weight-maintenance-trial/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "55661144-769f-3ff6-a59a-dfbc91235763",
      "content": {
        "id": "55661144-769f-3ff6-a59a-dfbc91235763",
        "contentType": "STORY",
        "title": "Eli Lilly’s oral GLP-1RA maintains weight loss from injectable drugs",
        "description": "",
        "summary": "Lilly has now submitted a new drug application (NDA) for orforglipron to the FDA for use in adults with obesity.",
        "pubDate": "2025-12-19T11:40:40Z",
        "displayTime": "2025-12-19T11:40:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/3b072f38289165b35f4477457f862bc7",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Eli Lilly's oral GLP-1RA",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l5fEIHA4QhzfNW_NgJg12g--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/3b072f38289165b35f4477457f862bc7.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tU7tHL87faS1htB7I4vb8w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/3b072f38289165b35f4477457f862bc7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/eli-lilly-orforglipron-phase-iii-obesity-weight-maintenance-trial/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-oral-glp-1ra-114040778.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T06:30:00+00:00",
    "headline": "Elanco CEO Bites Off More Shares of Fast-Rising Stock",
    "summary": "Elanco Animal Health  stock is having a great year—and Chief Executive Jeffrey Simmons is champing at the bit.  Simmons spent $478,500 to buy 22,000 shares of the stock on Dec. 11 for an average price of $21.75, according to a Form 4 filed with the Securities and Exchange Commission.  The purchase was made by a revocable trust and brings his total indirect ownership to 167,000 shares.",
    "url": "https://www.barrons.com/articles/elanco-ceo-stock-price-buy-2cd8bfdc?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "7a4c1c98-6ec6-3e69-ace7-9b21632b710b",
      "content": {
        "id": "7a4c1c98-6ec6-3e69-ace7-9b21632b710b",
        "contentType": "STORY",
        "title": "Elanco CEO Bites Off More Shares of Fast-Rising Stock",
        "description": "",
        "summary": "Elanco Animal Health  stock is having a great year—and Chief Executive Jeffrey Simmons is champing at the bit.  Simmons spent $478,500 to buy 22,000 shares of the stock on Dec. 11 for an average price of $21.75, according to a Form 4 filed with the Securities and Exchange Commission.  The purchase was made by a revocable trust and brings his total indirect ownership to 167,000 shares.",
        "pubDate": "2025-12-19T06:30:00Z",
        "displayTime": "2025-12-19T06:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7a4c1c98-6ec6-3e69-ace7-9b21632b710b/elanco-ceo-bites-off-more.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/bf776647ebe3b3271c0ab8172ec41d68",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ul8c3lkzPZ1nRklfTFfvHQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/bf776647ebe3b3271c0ab8172ec41d68.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w7Brg8mhI_kGJzQH8j4LDQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/bf776647ebe3b3271c0ab8172ec41d68.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/elanco-ceo-stock-price-buy-2cd8bfdc?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELAN"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T19:44:47+00:00",
    "headline": "Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump",
    "summary": "Dow Jones stock Merck struck a Most Favored Nation agreement with the Trump administration on Friday, joining other pharma bellwethers.",
    "url": "https://www.investors.com/news/technology/merck-most-favored-nation-drug-pricing-deal/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "2cb395b6-a638-3e88-a9aa-fb560f3deaa3",
      "content": {
        "id": "2cb395b6-a638-3e88-a9aa-fb560f3deaa3",
        "contentType": "STORY",
        "title": "Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump",
        "description": "",
        "summary": "Dow Jones stock Merck struck a Most Favored Nation agreement with the Trump administration on Friday, joining other pharma bellwethers.",
        "pubDate": "2025-12-19T19:44:47Z",
        "displayTime": "2025-12-19T19:44:47Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/2cb395b6-a638-3e88-a9aa-fb560f3deaa3/dow-jones-merck-other.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/3a897c85d50513809da70438e2285a69",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J52TnzuAhPRkxQcQYwjwUg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3a897c85d50513809da70438e2285a69.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Jcx0qKVoS.mXc1N2ud7p5Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/3a897c85d50513809da70438e2285a69.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/merck-most-favored-nation-drug-pricing-deal/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T17:15:00+00:00",
    "headline": "Pharma's $370B Bet on America: The ETF Plays for 2026",
    "summary": "Pharma ETFs like IHE are gaining traction as drugmakers pledge $370 billion to U.S. projects, fueling a new investment super-cycle heading into 2026.",
    "url": "https://finance.yahoo.com/news/pharmas-370b-bet-america-etf-171500181.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "33fcaabd-c7f4-3fb2-94b5-2bcf58713c2e",
      "content": {
        "id": "33fcaabd-c7f4-3fb2-94b5-2bcf58713c2e",
        "contentType": "STORY",
        "title": "Pharma's $370B Bet on America: The ETF Plays for 2026",
        "description": "",
        "summary": "Pharma ETFs like IHE are gaining traction as drugmakers pledge $370 billion to U.S. projects, fueling a new investment super-cycle heading into 2026.",
        "pubDate": "2025-12-19T17:15:00Z",
        "displayTime": "2025-12-19T17:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/829e973ee4e0f9b8c53ec82f52e62f8e",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZemfjVvYBRw3W8.nEBguuA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/829e973ee4e0f9b8c53ec82f52e62f8e.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wNN8n2_YU3n6CER2COkU_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/829e973ee4e0f9b8c53ec82f52e62f8e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pharmas-370b-bet-america-etf-171500181.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharmas-370b-bet-america-etf-171500181.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "IHE"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVSEF"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PJP"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T16:42:00+00:00",
    "headline": "White House Will Announce Pricing Deals With More Drugmakers Friday",
    "summary": "The Trump administration has talked tough about cutting drug prices, but the impacts of the deals with drug companies announced thus far have been limited.",
    "url": "https://www.barrons.com/articles/trump-drug-prices-pharmaceutical-9a04e4f5?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "af431dd1-182d-36f0-bd26-58acf64a3210",
      "content": {
        "id": "af431dd1-182d-36f0-bd26-58acf64a3210",
        "contentType": "STORY",
        "title": "White House Will Announce Pricing Deals With More Drugmakers Friday",
        "description": "",
        "summary": "The Trump administration has talked tough about cutting drug prices, but the impacts of the deals with drug companies announced thus far have been limited.",
        "pubDate": "2025-12-19T16:42:00Z",
        "displayTime": "2025-12-19T16:42:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/af431dd1-182d-36f0-bd26-58acf64a3210/white-house-will-announce.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/b84973a4d2302435aaade39667770556",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0M1QXHPJoerma0suNcmL3w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/b84973a4d2302435aaade39667770556.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S12Xvmf6XJVD1f.9zynb9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/b84973a4d2302435aaade39667770556.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/trump-drug-prices-pharmaceutical-9a04e4f5?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T15:52:18+00:00",
    "headline": "Did Eli Lilly Just Find the Holy Grail of Weight Loss?",
    "summary": "Eli Lilly (NYSE:LLY) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss. Its Zepbound injection has driven strong sales, contributing to the company’s overall revenue growth in the midst of intense demand for obesity therapies. In a head-to-head Phase 3 trial, Zepbound demonstrated superior efficacy, with patients achieving 20.2% average weight ... Did Eli Lilly Just Find the Holy Grail of Weight Loss?",
    "url": "https://247wallst.com/investing/2025/12/19/did-eli-lilly-just-find-the-holy-grail-of-weight-loss/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b69c49e5-933c-3324-aa4b-d85960f96454",
      "content": {
        "id": "b69c49e5-933c-3324-aa4b-d85960f96454",
        "contentType": "STORY",
        "title": "Did Eli Lilly Just Find the Holy Grail of Weight Loss?",
        "description": "",
        "summary": "Eli Lilly (NYSE:LLY) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss. Its Zepbound injection has driven strong sales, contributing to the company’s overall revenue growth in the midst of intense demand for obesity therapies. In a head-to-head Phase 3 trial, Zepbound demonstrated superior efficacy, with patients achieving 20.2% average weight ... Did Eli Lilly Just Find the Holy Grail of Weight Loss?",
        "pubDate": "2025-12-19T15:52:18Z",
        "displayTime": "2025-12-19T15:52:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/98e9534c2079a0230281ac42ca2cca10",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Bmkda1dlMEGr5QaTF2oLrQ--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/98e9534c2079a0230281ac42ca2cca10.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rl_bGJANteGLqpoItcTsgw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/98e9534c2079a0230281ac42ca2cca10.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/12/19/did-eli-lilly-just-find-the-holy-grail-of-weight-loss/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/did-eli-lilly-just-holy-155218199.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T15:46:00+00:00",
    "headline": "Pfizer Down After It Issues Muted 2026 Outlook: How to Play the Stock",
    "summary": "Pfizer shares fall after a muted 2026 outlook, with projected modest revenue growth, lower COVID sales and deal dilution weighing on investor sentiment.",
    "url": "https://finance.yahoo.com/news/pfizer-down-issues-muted-2026-154600786.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9418b507-4909-32a3-933b-cd93a6c3ec0a",
      "content": {
        "id": "9418b507-4909-32a3-933b-cd93a6c3ec0a",
        "contentType": "STORY",
        "title": "Pfizer Down After It Issues Muted 2026 Outlook: How to Play the Stock",
        "description": "",
        "summary": "Pfizer shares fall after a muted 2026 outlook, with projected modest revenue growth, lower COVID sales and deal dilution weighing on investor sentiment.",
        "pubDate": "2025-12-19T15:46:00Z",
        "displayTime": "2025-12-19T15:46:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YqcOBKMNrThKvJSga1KIbw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Vj9Bix098SQE5mY9G0P2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-down-issues-muted-2026-154600786.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-down-issues-muted-2026-154600786.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T21:07:00+00:00",
    "headline": "Lilly Shares Have Tripled on Weight-Loss Drugs. Why the Stock Looks Cheap.",
    "summary": "The growth potential of the weight-loss market could explode with advances, notably GLP-1 pills, and broader insurance coverage. That should change both health outcomes and the way Americas buy and consume food.",
    "url": "https://www.barrons.com/articles/eli-lilly-stock-price-weight-loss-drugs-ec064ec5?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "cbe982ce-03ff-36aa-830d-8dab863a2362",
      "content": {
        "id": "cbe982ce-03ff-36aa-830d-8dab863a2362",
        "contentType": "STORY",
        "title": "Lilly Shares Have Tripled on Weight-Loss Drugs. Why the Stock Looks Cheap.",
        "description": "",
        "summary": "The growth potential of the weight-loss market could explode with advances, notably GLP-1 pills, and broader insurance coverage. That should change both health outcomes and the way Americas buy and consume food.",
        "pubDate": "2025-12-19T21:07:00Z",
        "displayTime": "2025-12-19T21:07:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cbe982ce-03ff-36aa-830d-8dab863a2362/lilly-shares-have-tripled-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/44f7aff5d119d99ce24fdbd15b263a6a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aRnbDLpqfc5mD3lZI61TQA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/44f7aff5d119d99ce24fdbd15b263a6a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MpEOz9Fx98Tg1WHNumWgzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/44f7aff5d119d99ce24fdbd15b263a6a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/eli-lilly-stock-price-weight-loss-drugs-ec064ec5?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T21:01:16+00:00",
    "headline": "Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc",
    "summary": "Exploring the Fund's Recent Portfolio Adjustments",
    "url": "https://finance.yahoo.com/news/vanguard-health-care-funds-strategic-210116241.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "434fab9d-e658-3ff3-b054-87ae6ed8981a",
      "content": {
        "id": "434fab9d-e658-3ff3-b054-87ae6ed8981a",
        "contentType": "STORY",
        "title": "Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc",
        "description": "",
        "summary": "Exploring the Fund's Recent Portfolio Adjustments",
        "pubDate": "2025-12-19T21:01:16Z",
        "displayTime": "2025-12-19T21:01:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/c91c7aef460400014805e552dc5dc8a1",
          "originalWidth": 1242,
          "originalHeight": 902,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pZc6vON9fkNCJ8SD2BnrHA--~B/aD05MDI7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/c91c7aef460400014805e552dc5dc8a1.cf.webp",
              "width": 1242,
              "height": 902,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hmPp825PBifZ_hZqvSj9fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/c91c7aef460400014805e552dc5dc8a1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vanguard-health-care-funds-strategic-210116241.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vanguard-health-care-funds-strategic-210116241.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T20:14:00+00:00",
    "headline": "White House Cuts Drug-Pricing Deals With Pharma Companies, Tilting System Toward Self-Pay",
    "summary": "The Trump administration has talked tough on drug prices, but the impact of its deals with drugmakers so far has been limited.",
    "url": "https://www.barrons.com/articles/trump-drug-prices-pharmaceutical-9a04e4f5?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "af431dd1-182d-36f0-bd26-58acf64a3210",
      "content": {
        "id": "af431dd1-182d-36f0-bd26-58acf64a3210",
        "contentType": "STORY",
        "title": "White House Cuts Drug-Pricing Deals With Pharma Companies, Tilting System Toward Self-Pay",
        "description": "",
        "summary": "The Trump administration has talked tough on drug prices, but the impact of its deals with drugmakers so far has been limited.",
        "pubDate": "2025-12-19T20:14:00Z",
        "displayTime": "2025-12-19T20:14:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/af431dd1-182d-36f0-bd26-58acf64a3210/white-house-cuts-drug-pricing.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/b84973a4d2302435aaade39667770556",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0M1QXHPJoerma0suNcmL3w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/b84973a4d2302435aaade39667770556.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S12Xvmf6XJVD1f.9zynb9A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/b84973a4d2302435aaade39667770556.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/trump-drug-prices-pharmaceutical-9a04e4f5?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]